World Diabetes Day
World Diabetes Day was coined by the World Health Organization (WHO) and the International Diabetes Federation (IDF) in 2006. It has since been celebrated every year on November 14th.
Its purpose has been to promote the need to take coordinated and concerted actions to confront diabetes as a critical global health issue.
Diabetes has now become one of the world’s leading non-communicable diseases that affect the body’s ability to make or use insulin. There are three main types of diabetes – type 1, type 2, and gestational. The body’s blood sugar levels are remarkably constant and rarely outside the range of 3.5‐8.0 mmol/L but if an individual record continues fasting blood sugar over 8 mmo1/L or a random value over 11.1 mmo1/L the person is said to be diabetic.
| UPDATED: 18:07, Tue, Dec 15, 2020
Link copied Sign up for FREE health tips to live a long and happy life
SUBSCRIBE Invalid email
When you subscribe we will use the information you provide to send you these newsletters. Sometimes they ll include recommendations for other related newsletters or services we offer. Our Privacy Notice explains more about how we use your data, and your rights. You can unsubscribe at any time.
A healthy diet is important for a healthy life, as stated by the old saying, “You are what you eat”. This is even more important in today’s world where diabetes and obesity are a worldwide pandemic. According to the International Diabetes Federation 8th Diabetes Atlas, about 425 million people worldwide have diabetes and, if the current trends continue, 629 million of people aged 20–79 will have diabetes by 2045. With these shocking statistics finding ways to help with better treatment is imperative. Studies and health experts agree that a low carb
Sensyne Health Launches First Digital Health Product in the U.S.
OXFORD, England–(BUSINESS WIRE)–Sensyne Health plc (LSE: SENS) (“Sensyne” or the “Company” or the “Group”), the British Clinical AI technology company, today announces that it has launched GDm-Health, its remote monitoring solution for diabetes in pregnancy, in the U.S. with immediate effect.
Sensyne’s sales and marketing partner for the U.S., Cognizant, is now offering the solution to U.S. health systems and health plans via its sales force. Virtual care services powered by GDm-Health will qualify for reimbursement under remote patient monitoring codes introduced by the Centers for Medicare and Medicaid Services (CMS) in 2020.
Search jobs 15-Dec-2020 The Rapid Acting Insulin Opportunity Analysis Market to exhibit stampede over economic slowdown in the next 10 years
Rapid acting insulin are insulin analogs developed to imitate meal induced insulin secretion. These analogs are usually preferred over regular insulin because of their fast response, allowing diabetes patients to take it intravenously before any meal. Advances in rapid acting insulin opportunity analysis is essential for diabetes management, however clinical safety and efficacy also needs to be considered. By conducting rapid acting insulin opportunity analysis assessment, increased availability of continuous glucose monitoring will help in intricate analysis of clinical rapid insulin action which was not previously possible. It will help in knowing if the new rapid acting insulin opportunity analysis will provide a better level of optimal glycemic control above HbA1c levels, which is required
Switzerland Biosensors Market is Expected to Witness Significant Growth by 2026 comunicati.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from comunicati.net Daily Mail and Mail on Sunday newspapers.